Episode Details

Sermorelin has a half-life of just 10 to 12 minutes — so how does something that leaves your system that fast do anything at all? That's the question Dr. Kylie Burton and Jessica Brickie open with in this episode, using it as the jumping-off point for a side-by-side look at two related growth hormone peptides: sermorelin and tesamorelin.

The hosts explain sermorelin's core mechanism — a "gentle nudge" to the pituitary gland that prompts the body to release its own growth hormone in its natural pulsing rhythm, rather than forcing a large spike. They contrast that with tesamorelin, the more potent, FDA-approved (for HIV-associated lipodystrophy) option that's more targeted toward visceral fat. Both are used off-label in adult wellness for goals well beyond their approved indications, and the hosts are upfront about that distinction throughout.

From there, the conversation moves into what people actually notice when starting sermorelin — deeper, more restorative sleep; a general sense of vitality; and steadier energy without the afternoon crash — along with an honest look at what's well-established research versus what's still associated/anecdotal. 

The hosts also spend meaningful time on one of their favorite applications: perimenopausal and postmenopausal women, where growth hormone decline compounds with the broader hormonal shifts of menopause, affecting sleep, energy, recovery, and bone density.

What You'll Learn

• Why sermorelin's short half-life is the point, not a limitation — it restores a natural release rhythm instead of forcing a spike
• The mechanism behind sermorelin: mimicking GHRH to stimulate the pituitary gland's own growth hormone release
• Sermorelin vs. tesamorelin, side by side: potency, FDA-approved indications, off-label adult use, side effect profile, and cost
• Why tesamorelin is often thought of as the sharper, more targeted tool (visceral fat), while sermorelin functions more like a daily foundation
• The three things people notice first: deeper sleep, overall vitality, and steadier energy
• How sermorelin's energy mechanism differs from other options like MOT-C or NAD+ — and why it might be worth trying if those haven't worked for you
• What's backed by solid mechanistic research versus what's associated/anecdotal — and why this is a conversation to have with your own provider
• Why sermorelin is often described as a good "front door" peptide for people new to peptide therapy or nervous about starting with something stronger
• Why growth hormone decline hits an extra inflection point during the menopause transition — and how that ties into sleep, energy, recovery, and bone density for women in perimenopause and postmenopause

Segment Breakdown

• The 12-Minute Half-Life Mystery — Why sermorelin's fast clearance is actually the mechanism, not a flaw
• Gentle Nudge Versus Big Push — How sermorelin restores natural GH pulsing rather than forcing a spike
• Sermorelin Versus Tesamorelin — FDA-approved indications, off-label use, potency, and cost comparison
• What People Notice First — Sleep, vitality, and energy as the three most common reported effects
• What We Know and Don't — Separating established mechanism from anecdotal, individual-level outcomes
• Menopause, Bone Density, Recovery — Why this life stage is one of the hosts' favorite applications for sermorelin
• Medical Oversight and Where to Find Us — Why provider oversight matters and where to connect with the hosts

Where do you start with peptide therapy? What do you add next? If you're a go-getter, check out Dr. Kylie's new program AMPLIFY. You'll find it on the homepage of her website: drkylieburton.com

Ready to explore peptide